A detailed history of D. E. Shaw & Co., Inc. transactions in Mannkind Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 2,701,255 shares of MNKD stock, worth $13.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,701,255
Previous 2,988,025 9.6%
Holding current value
$13.9 Million
Previous $10.9 Million 12.5%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$3.25 - $5.27 $932,002 - $1.51 Million
-286,770 Reduced 9.6%
2,701,255 $12.2 Million
Q4 2023

Feb 14, 2024

SELL
$3.34 - $4.29 $4.07 Million - $5.23 Million
-1,219,366 Reduced 28.98%
2,988,025 $10.9 Million
Q3 2023

Nov 14, 2023

BUY
$3.91 - $5.45 $883,057 - $1.23 Million
225,846 Added 5.67%
4,207,391 $17.4 Million
Q2 2023

Aug 14, 2023

SELL
$3.72 - $4.79 $6.8 Million - $8.76 Million
-1,828,508 Reduced 31.47%
3,981,545 $16.2 Million
Q1 2023

May 15, 2023

BUY
$3.95 - $5.63 $819,064 - $1.17 Million
207,358 Added 3.7%
5,810,053 $23.8 Million
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $6.42 Million - $11.4 Million
2,124,534 Added 61.08%
5,602,695 $29.5 Million
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $689,093 - $1 Million
230,466 Added 7.1%
3,478,161 $10.7 Million
Q2 2022

Aug 15, 2022

BUY
$2.67 - $4.77 $5.33 Million - $9.52 Million
1,994,946 Added 159.25%
3,247,695 $12.4 Million
Q1 2022

May 16, 2022

BUY
$2.62 - $4.45 $3.28 Million - $5.57 Million
1,252,749 New
1,252,749 $4.61 Million
Q3 2020

Nov 16, 2020

SELL
$1.56 - $2.08 $37,235 - $49,647
-23,869 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$0.94 - $2.21 $632,845 - $1.49 Million
-673,240 Reduced 96.58%
23,869 $42,000
Q1 2020

May 15, 2020

SELL
$0.84 - $1.76 $390,654 - $818,514
-465,065 Reduced 40.02%
697,109 $718,000
Q4 2019

Feb 14, 2020

SELL
$1.14 - $1.49 $104,428 - $136,489
-91,604 Reduced 7.31%
1,162,174 $1.5 Million
Q3 2019

Nov 14, 2019

SELL
$1.04 - $1.44 $839,190 - $1.16 Million
-806,914 Reduced 39.16%
1,253,778 $1.57 Million
Q2 2019

Aug 14, 2019

SELL
$1.09 - $1.88 $1.12 Million - $1.92 Million
-1,023,189 Reduced 33.18%
2,060,692 $2.37 Million
Q1 2019

May 15, 2019

BUY
$1.14 - $2.25 $2.13 Million - $4.21 Million
1,869,543 Added 153.96%
3,083,881 $6.08 Million
Q4 2018

Feb 14, 2019

SELL
$1.02 - $2.05 $709,774 - $1.43 Million
-695,857 Reduced 36.43%
1,214,338 $1.29 Million
Q3 2018

Nov 14, 2018

SELL
$1.01 - $2.19 $2.06 Million - $4.47 Million
-2,040,598 Reduced 51.65%
1,910,195 $3.5 Million
Q2 2018

Aug 14, 2018

SELL
$1.59 - $2.38 $1.65 Million - $2.47 Million
-1,037,412 Reduced 20.8%
3,950,793 $7.51 Million
Q1 2018

May 15, 2018

BUY
$2.28 - $3.8 $2.2 Million - $3.66 Million
963,649 Added 23.94%
4,988,205 $11.4 Million
Q4 2017

Feb 14, 2018

BUY
$2.28 - $6.71 $6.38 Million - $18.8 Million
2,796,577 Added 227.74%
4,024,556 $9.34 Million
Q3 2017

Nov 14, 2017

BUY
$1.15 - $2.29 $1.41 Million - $2.81 Million
1,227,979
1,227,979 $2.67 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.32B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.